{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:16:03Z","timestamp":1783476963883,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023035, 202446"],"award-info":[{"award-number":["2023035, 202446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06469-x","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:34:32Z","timestamp":1778394872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced detection of bladder cancer using combined circulating tumor cells, urine-derived epithelial cells, and molecular biomarkers"],"prefix":"10.1007","volume":"152","author":[{"given":"Zhijie","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"issue":"3","key":"6469_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","volume":"35","author":"H Ahmadi","year":"2021","unstructured":"Ahmadi H, Duddalwar V et al (2021) Diagnosis and staging of bladder cancer. Hematol Oncol Clin North Am 35(3):531\u2013541","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"6469_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.juro.2015.02.2951","volume":"194","author":"A Alva","year":"2015","unstructured":"Alva A, Friedlander T et al (2015) Circulating tumor cells as potential biomarkers in bladder cancer. J Urol 194(3):790\u2013798","journal-title":"J Urol"},{"issue":"6","key":"6469_CR3","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cancers14061520","volume":"14","author":"\u0141 Bia\u0142ek","year":"2022","unstructured":"Bia\u0142ek \u0141, Bilski K et al (2022) Non-invasive biomarkers in the diagnosis of upper urinary tract urothelial carcinoma-A systematic review. Cancers (Basel) 14(6):1520","journal-title":"Cancers (Basel)"},{"issue":"3","key":"6469_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"6469_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncy.20099","volume":"118","author":"NP Caraway","year":"2010","unstructured":"Caraway NP, Khanna A et al (2010) Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study. Cancer Cytopathol 118(5):259\u2013268","journal-title":"Cancer Cytopathol"},{"key":"6469_CR6","doi-asserted-by":"publisher","first-page":"103577","DOI":"10.1016\/j.critrevonc.2022.103577","volume":"170","author":"F Crocetto","year":"2022","unstructured":"Crocetto F, Barone B et al (2022) Liquid biopsy in bladder cancer: state of the art and future perspectives. Crit Rev Oncol Hematol 170:103577","journal-title":"Crit Rev Oncol Hematol"},{"key":"6469_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-0716-3346-5_7","volume":"2695","author":"Y Cui","year":"2023","unstructured":"Cui Y, Cao M (2023) Liquid biopsy in bladder cancer. Methods Mol Biol 2695:111\u2013120","journal-title":"Methods Mol Biol"},{"issue":"8","key":"6469_CR8","first-page":"507","volume":"96","author":"KC DeGeorge","year":"2017","unstructured":"DeGeorge KC, Holt HR et al (2017) Bladder cancer: diagnosis and treatment. Am Fam Physician 96(8):507\u2013514","journal-title":"Am Fam Physician"},{"issue":"1\u20132","key":"6469_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cccn.2003.11.008","volume":"340","author":"P Dey","year":"2004","unstructured":"Dey P (2004) Urinary markers of bladder carcinoma. Clin Chim Acta 340(1\u20132):57\u201365","journal-title":"Clin Chim Acta"},{"issue":"15","key":"6469_CR10","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.3390\/ijms241512489","volume":"24","author":"V Fiorentino","year":"2023","unstructured":"Fiorentino V, Pizzimenti C et al (2023) Bladder epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples. Int J Mol Sci 24(15):12489","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6469_CR11","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1002\/cam4.5481","volume":"12","author":"F Gao","year":"2023","unstructured":"Gao F, Wang J et al (2023) Comprehensive optimization of urinary exfoliated tumor cells tests in bladder cancer with a promising microfluidic platform. Cancer Med 12(6):7283\u20137293","journal-title":"Cancer Med"},{"issue":"9","key":"6469_CR12","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3390\/cancers14092171","volume":"14","author":"C Gutierrez","year":"2022","unstructured":"Gutierrez C, Pinson X et al (2022) Characterization of the peri-membrane fluorescence phenomenon allowing the detection of urothelial tumor cells in urine. Cancers (Basel) 14(9):2171","journal-title":"Cancers (Basel)"},{"issue":"23","key":"6469_CR13","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.3390\/cancers13236040","volume":"13","author":"MJ Hoffmann","year":"2021","unstructured":"Hoffmann MJ, Schulz WA (2021) Alterations of chromatin regulators in the pathogenesis of urinary bladder urothelial carcinoma. Cancers (Basel) 13(23):6040","journal-title":"Cancers (Basel)"},{"key":"6469_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/OTT.S31368","volume":"5","author":"X-Y Jia","year":"2012","unstructured":"Jia X-Y, Yu Q et al (2012) Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand. OncoTargets Ther 5:85\u201390","journal-title":"OncoTargets Ther"},{"issue":"2","key":"6469_CR15","first-page":"309","volume":"14","author":"K Junker","year":"1999","unstructured":"Junker K, Werner W et al (1999) Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing. Int J Oncol 14(2):309\u2013313","journal-title":"Int J Oncol"},{"issue":"2","key":"6469_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/ol.2013.1744","volume":"7","author":"Z Ke","year":"2014","unstructured":"Ke Z, Lai Y et al (2014) Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization. Oncol Lett 7(2):325\u2013330","journal-title":"Oncol Lett"},{"issue":"14","key":"6469_CR17","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.7150\/jca.30079","volume":"10","author":"T-J Kim","year":"2019","unstructured":"Kim T-J, Moon HW et al (2019) Urovysion FISH could be effective and useful method to confirm the identity of cultured circulating tumor cells from bladder cancer patients. J Cancer 10(14):3259\u20133266","journal-title":"J Cancer"},{"issue":"16","key":"6469_CR18","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.3390\/ijms23169148","volume":"23","author":"D Koguchi","year":"2022","unstructured":"Koguchi D, Matsumoto K et al (2022) Diagnostic potential of circulating tumor cells, urinary microRNA, and urinary cell-free DNA for bladder cancer: a review. Int J Mol Sci 23(16):9148","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6469_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1541-7786.MCR-06-0069","volume":"5","author":"S-M Lee","year":"2007","unstructured":"Lee S-M, Lee E-J et al (2007) Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res 5(1):11\u201319","journal-title":"Mol Cancer Res"},{"key":"6469_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.aca.2018.07.044","volume":"1044","author":"L Liang","year":"2018","unstructured":"Liang L, Wang Y et al (2018) Microchips for detection of exfoliated tumor cells in urine for identification of bladder cancer. Anal Chim Acta 1044:93\u2013101","journal-title":"Anal Chim Acta"},{"issue":"10","key":"6469_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12032-017-1033-z","volume":"34","author":"EIML Liem","year":"2017","unstructured":"Liem EIML, Baard J et al (2017) Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Gu\u00e9rin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer. Med Oncol 34(10):172","journal-title":"Med Oncol"},{"issue":"7","key":"6469_CR22","doi-asserted-by":"publisher","first-page":"e14573","DOI":"10.1097\/MD.0000000000014573","volume":"98","author":"T Lin","year":"2019","unstructured":"Lin T, Jin H et al (2019) Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization: protocol for a systematic review and meta-analysis. Medicine (Baltimore) 98(7):e14573","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"6469_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/cncy.22884","volume":"132","author":"T-J Liu","year":"2024","unstructured":"Liu T-J, Yang W-C et al (2024) Evaluating artificial intelligence\u2013enhanced digital urine cytology for bladder cancer diagnosis. Cancer Cytopathol 132(11):686\u2013695","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"6469_CR24","first-page":"4761","volume":"30","author":"M Maffezzini","year":"2010","unstructured":"Maffezzini M, Campodonico F et al (2010) Prognostic significance of fluorescent in situ hybridization in the follow-up of non-muscle-invasive bladder cancer. Anticancer Res 30(11):4761\u20134765","journal-title":"Anticancer Res"},{"issue":"10","key":"6469_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iju.13376","volume":"24","author":"J Miyazaki","year":"2017","unstructured":"Miyazaki J, Nishiyama H (2017) Epidemiology of urothelial carcinoma. Int J Urol 24(10):730\u2013734","journal-title":"Int J Urol"},{"issue":"2","key":"6469_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/UA.UA_192_17","volume":"11","author":"AS Muhammad","year":"2019","unstructured":"Muhammad AS, Mungadi IA et al (2019) Effectiveness of bladder tumor antigen quantitative test in the diagnosis of bladder carcinoma in a schistosome endemic area. Urol Ann 11(2):143\u2013148","journal-title":"Urol Ann"},{"issue":"3","key":"6469_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02893498","volume":"13","author":"P Riesz","year":"2007","unstructured":"Riesz P, Lotz G et al (2007) Detection of bladder cancer from the urine using fluorescence in situ hybridization technique. Pathol Oncol Res 13(3):187\u2013194","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"6469_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41585-024-00904-9","volume":"22","author":"E Shkolyar","year":"2025","unstructured":"Shkolyar E, Zhou SR et al (2025) Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence. Nat Rev Urol 22(1):46\u201354","journal-title":"Nat Rev Urol"},{"issue":"6","key":"6469_CR29","first-page":"992","volume":"10","author":"M Silva-Ferreira","year":"2024","unstructured":"Silva-Ferreira M, Carvalho JA et al (2024) Diagnostic test accuracy of urinary DNA methylation-based biomarkers for the detection of primary and recurrent bladder cancer: a systematic review and meta-analysis. Eura Urol Focus 10(6):992\u2013934","journal-title":"Eura Urol Focus"},{"issue":"1","key":"6469_CR30","first-page":"502","volume":"15","author":"L Wang","year":"2023","unstructured":"Wang L, Ding D (2023) Correlation between mesenchymal circulating tumor cells and prognosis of urologic malignancies: a single-center retrospective analysis. Am J Transl Res 15(1):502\u2013510","journal-title":"Am J Transl Res"},{"issue":"1","key":"6469_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/cam4.2655","volume":"9","author":"X Wang","year":"2020","unstructured":"Wang X, Gu Y et al (2020) Unbiased enrichment of urine exfoliated cells on nanostructured substrates for sensitive detection of urothelial tumor cells. Cancer Med 9(1):290\u2013301","journal-title":"Cancer Med"},{"issue":"9","key":"6469_CR32","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.21037\/tcr-22-2920","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q, Li Z et al (2023) Clinical values of circulating tumor cells count in localized renal cell carcinoma. Transl Cancer Res 12(9):2351\u20132360","journal-title":"Transl Cancer Res"},{"issue":"3","key":"6469_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urolonc.2020.11.014","volume":"39","author":"JRE Wolfs","year":"2021","unstructured":"Wolfs JRE, Hermans TJN et al (2021) Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: a review. Urol Oncol 39(3):161\u2013170","journal-title":"Urol Oncol"},{"key":"6469_CR34","doi-asserted-by":"publisher","first-page":"115027","DOI":"10.1016\/j.biopha.2023.115027","volume":"165","author":"S Wu","year":"2023","unstructured":"Wu S, Li R et al (2023) Liquid biopsy in urothelial carcinoma: detection techniques and clinical applications. Biomed Pharmacother 165:115027","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6469_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12951-021-01104-y","volume":"19","author":"Y Xu","year":"2021","unstructured":"Xu Y, Luo C et al (2021) Application of nanotechnology in the diagnosis and treatment of bladder cancer. J Nanobiotechnol 19(1):393","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"6469_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jasc.2020.06.011","volume":"10","author":"ML Zhang","year":"2021","unstructured":"Zhang ML, VandenBussche CJ et al (2021) A review of urinary cytology in the setting of upper tract urothelial carcinoma. J Am Soc Cytopathol 10(1):29\u201335","journal-title":"J Am Soc Cytopathol"},{"issue":"8","key":"6469_CR37","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/diagnostics12082005","volume":"12","author":"W Zheng","year":"2022","unstructured":"Zheng W, Lin T et al (2022) An updated systematic review and meta-analysis. Diagnostics (Basel) 12(8):2005","journal-title":"Diagnostics (Basel)"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06469-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06469-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06469-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:20:54Z","timestamp":1783473654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06469-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6469"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06469-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8819995\/v1","asserted-by":"object"}]},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants provided written informed consent using a form specifically approved for this research by the Ethics\/Institutional Review Board of Yichang Central People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"131"}}